Treatment of posttransplantation recurrence of hepatitis C with interferon and ribavirin: Lessons on tolerability and efficacy-Reference-Cited by-同舟云学术

Treatment of posttransplantation recurrence of hepatitis C with interferon and ribavirin: Lessons on tolerability and efficacy

Published:2002-07 Issue:7 Volume:8 Page:623-629
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transplantation

Author:

Narayanan Menon K

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Reference39 articles.

1. Recent findings concerning liver transplantation in the United States. In: Clinical Transplants 1996. Los Angeles: UCLA Tissue Typing Laboratory; 1997: 15-30.

2. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C

3. Recurrent and acquired hepatitis C viral infection in liver transplant recipients

4. Clinical Outcomes after Transfusion-Associated Hepatitis C

5. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safe use of livers from deceased donors older than 70 years in recipients with HCV cirrhosis treated with direct-action antivirals. Retrospective cohort study;International Journal of Surgery;2021-07

2. Sofosbuvir/Ledipasvir Without Ribavirin Achieved High Sustained Virologic Response for Hepatitis C Recurrence After Liver Transplantation;Transplantation;2017-05

3. Ledipasvir and sofosbuvir for recurrent hepatitis C after liver transplantation;BioScience Trends;2016

4. 6. Viral Hepatitis and Liver Transplantation;Nihon Naika Gakkai Zasshi;2013

5. Long-Term Management of Recurrent Primary Liver Disease;Textbook of Clinical Gastroenterology and Hepatology;2012-04-16